- Research works
- 8 ▼ 59% vs 2013–17
- Citations
- 45 5.4 per fractional work
- Top-10% rate
- 4.0% record average 16.5%
- Open access
- 85% world 28%
Not ranked overall: AxioMx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does AxioMx (United States) publish most on?
By volume: Adversarial Robustness in Machine Learning, Ethics and Social Impacts of AI, Food Supply Chain Traceability and Glycosylation and Glycoproteins Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Adversarial Robustness in Machine Learning Artificial Intelligence 1 works
- 2 Ethics and Social Impacts of AI Safety Research 1 works
- 3 Food Supply Chain Traceability Food Science 1 works
- 4 Glycosylation and Glycoproteins Research Molecular Biology 1 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 6 Protein purification and stability Molecular Biology 0 works
- 7 Computational Physics and Python Applications Artificial Intelligence 0 works
- 8 Polish Legal and Social Issues Law 0 works
- 9 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 10 CRISPR and Genetic Engineering Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AxioMx (United States)'s research output changed?
Output in 2018–2022 was 59% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Branford
- Wren Laboratories (United States)
- Institute for Diabetes Discovery
- IsoPlexis (United States)
- Anchor Science (United States)
- CheminPharma (United States)
- Axerion Therapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.